61,273 Shares in Cryoport, Inc. (NASDAQ:CYRX) Purchased by State of New Jersey Common Pension Fund D

State of New Jersey Common Pension Fund D purchased a new position in shares of Cryoport, Inc. (NASDAQ:CYRXGet Rating) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 61,273 shares of the consumer goods maker’s stock, valued at approximately $1,493,000. State of New Jersey Common Pension Fund D owned about 0.13% of Cryoport as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Connors Investor Services Inc. grew its holdings in shares of Cryoport by 51.0% during the second quarter. Connors Investor Services Inc. now owns 131,021 shares of the consumer goods maker’s stock worth $4,059,000 after buying an additional 44,245 shares during the last quarter. DF Dent & Co. Inc. boosted its holdings in Cryoport by 75.6% in the 2nd quarter. DF Dent & Co. Inc. now owns 173,410 shares of the consumer goods maker’s stock valued at $5,372,000 after purchasing an additional 74,635 shares in the last quarter. Redwood Investments LLC boosted its holdings in Cryoport by 63.1% in the 2nd quarter. Redwood Investments LLC now owns 433,106 shares of the consumer goods maker’s stock valued at $13,418,000 after purchasing an additional 167,485 shares in the last quarter. SG Americas Securities LLC purchased a new stake in Cryoport in the 2nd quarter valued at approximately $264,000. Finally, Forager Funds Management Pty Ltd boosted its holdings in Cryoport by 38.3% in the 2nd quarter. Forager Funds Management Pty Ltd now owns 161,826 shares of the consumer goods maker’s stock valued at $5,013,000 after purchasing an additional 44,809 shares in the last quarter. Hedge funds and other institutional investors own 88.66% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on CYRX shares. Needham & Company LLC lowered their price objective on Cryoport from $49.00 to $28.00 and set a “buy” rating on the stock in a report on Friday, November 4th. SVB Leerink reduced their price target on shares of Cryoport from $45.00 to $28.00 and set an “outperform” rating for the company in a research report on Friday, November 4th. B. Riley reduced their price target on shares of Cryoport from $55.00 to $30.00 and set a “buy” rating for the company in a research report on Wednesday, November 16th. Finally, KeyCorp reduced their price target on shares of Cryoport from $40.00 to $30.00 and set an “overweight” rating for the company in a research report on Thursday, December 8th. Four investment analysts have rated the stock with a buy rating, According to data from MarketBeat, Cryoport presently has a consensus rating of “Buy” and a consensus price target of $40.50.

Cryoport Trading Up 0.6 %

Shares of Cryoport stock opened at $21.75 on Friday. The company has a debt-to-equity ratio of 0.75, a current ratio of 14.96 and a quick ratio of 14.35. Cryoport, Inc. has a 1 year low of $15.63 and a 1 year high of $45.36. The company has a market capitalization of $1.07 billion, a P/E ratio of -3.54 and a beta of 1.24. The business has a 50 day moving average price of $18.68 and a 200 day moving average price of $26.80.

Cryoport (NASDAQ:CYRXGet Rating) last issued its quarterly earnings data on Thursday, November 3rd. The consumer goods maker reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.13) by ($0.02). Cryoport had a negative return on equity of 14.84% and a negative net margin of 123.41%. The company had revenue of $60.46 million for the quarter, compared to analyst estimates of $70.22 million. Sell-side analysts anticipate that Cryoport, Inc. will post -0.89 EPS for the current fiscal year.

Insider Buying and Selling

In other Cryoport news, Director Richard J. Berman sold 7,250 shares of Cryoport stock in a transaction that occurred on Thursday, December 1st. The shares were sold at an average price of $19.63, for a total value of $142,317.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 9.70% of the company’s stock.

Cryoport Company Profile

(Get Rating)

Cryoport, Inc, a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle.

See Also

Want to see what other hedge funds are holding CYRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cryoport, Inc. (NASDAQ:CYRXGet Rating).

Institutional Ownership by Quarter for Cryoport (NASDAQ:CYRX)

Receive News & Ratings for Cryoport Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryoport and related companies with MarketBeat.com's FREE daily email newsletter.